Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.035 USD | -3.27% | -6.99% | -24.51% |
May. 09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.51% | 206M | |
+6.68% | 113B | |
+11.18% | 106B | |
+0.90% | 22.27B | |
-12.53% | 22.22B | |
-5.61% | 19.43B | |
-37.85% | 17.87B | |
-6.52% | 17.24B | |
+7.45% | 14.29B | |
+34.67% | 12.52B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Transcript : Bluebird bio, Inc., Q4 2023 Earnings Call, Mar 26, 2024